AlphaFold predicted structure
TERF2IP · Q9NYB0

Mean pLDDT
72.1/ 100
Confident
399 residues
Confidence breakdown
- Very high(≥ 90)36%
- Confident(70–90)21%
- Low(50–70)14%
- Very low(< 50)29%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
TERF2 interacting protein
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Familial melanoma
smoking initiation
neoplasm
substance abuse
attention deficit-hyperactivity disorder
non-small cell lung carcinoma
obesity due to melanocortin 4 receptor deficiency
gastric cancer
MODY
Berardinelli-Seip congenital lipodystrophy
cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Telomeric repeat-binding factor 2-interacting protein 1
Acts both as a regulator of telomere function and as a transcription regulator. Involved in the regulation of telomere length and protection as a component of the shelterin complex (telosome). In contrast to other components of the shelterin complex, it is dispensible for telomere capping and does not participate in the protection of telomeres against non-homologous end-joining (NHEJ)-mediated repair. Instead, it is required to negatively regulate telomere recombination and is essential for repressing homology-directed repair (HDR), which can affect telomere length. Does not bind DNA directly: recruited to telomeric double-stranded 5'-TTAGGG-3' repeats via its interaction with TERF2. Independently of its function in telomeres, also acts as a transcription regulator: recruited to extratelomeric 5'-TTAGGG-3' sites via its association with TERF2 or other factors, and regulates gene expression. When cytoplasmic, associates with the I-kappa-B-kinase (IKK) complex and acts as a regulator of the NF-kappa-B signaling by promoting IKK-mediated phosphorylation of RELA/p65, leading to activate expression of NF-kappa-B target genes
TERF2IP · Q9NYB0

Mean pLDDT
72.1/ 100
Confident
399 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0